blood test

Business

Grifols strengthens its presence in the Chinese market

May 22, 2012 03:33 PM | CNA / Laura Quintana

The Catalan pharmaceutical company Grífols, third worldwide company in plasma derivatives, has signed a cooperation agreement with the Shanghai Blood Bank. The agreement, which strengthens the presence of the Catalan company in China, promotes blood genotyping research. The Chinese institution will use the Grifols’ genetic test BLOODchip in transfusion compatibility studies. Shanghai Blood Bank serves over 20 million people and receives more than 300.000 donations per year. In 2011, Grifols sales in China grew by 30%.

Society

A pioneer study led by a Catalan hospital supports an easier way to detect colon cancer

February 24, 2012 12:02 AM | CNA

Barcelona’s Hospital Clínic has coordinated a world pioneer medical study with 60,000 patients. The study has compared the effectiveness of early detection of colon cancer by using a colonoscopy or a specific analysis searching blood in the patients’ faeces. The findings have proven that both diagnostic tests are equally reliable. Considering the differences between the financial costs of both tests, health risks, and comfort, colonoscopy might only be used for confirmation or treatment purposes. In addition, from now on all people older than 50 might be regularly checked in an easier and cheaper manner.